
  
    
      
        Introduction_NNP
        The_DT term_NN '_'' sepsis_NN '_'' is_VBZ used_VBN to_TO define_VB the_DT systemic_JJ
        inflammatory_JJ response_NN to_TO an_DT infectious_JJ agent_NN (_( i_NNP ._. e_SYM ._.
        bacterial_JJ ,_, viral_JJ ,_, fungal_NN or_CC parasitic_JJ )_) ._. Despite_IN the_DT use_NN of_IN
        new_JJ treatment_NN modalities_NNS ,_, improvements_NNS in_IN technology_NN and_CC
        increased_VBN experience_NN ,_, mortality_NN rates_NNS in_IN sepsis_NN remain_VB high_JJ
        [_NN 1_CD ,_, 2_CD ]_NN ._. Critical_JJ care_NN physicians_NNS have_VBP at_IN their_PRP$ disposal_NN a_DT
        variety_NN of_IN data_NNS to_TO serve_VB as_IN a_DT guide_NN in_IN discriminating_VBG
        infectious_JJ from_IN noninfectious_JJ conditions_NNS in_IN newly_RB admitted_VBN
        patients_NNS ._. In_IN a_DT number_NN of_IN newly_RB admitted_VBN patients_NNS the_DT
        diagnosis_NN of_IN sepsis_NN becomes_VBZ clear_JJ after_IN taking_VBG the_DT medical_JJ
        history_NN and_CC completing_VBG the_DT physical_JJ examination_NN [_NN 3_CD ]_NN ._. In_IN
        other_JJ cases_NNS ,_, in_IN which_WDT noninfectious_JJ insults_NNS are_VBP responsible_JJ
        for_IN systemic_JJ inflammatory_JJ response_NN syndrome_NN (_( SIRS_NNP ;_: e_SYM ._. g_SYM ._.
        trauma_NN ,_, burns_NNS ,_, haemorrhages_NNS ,_, hypothermia_NN ,_, pancreatitis_NNS and_CC
        surgery_NN )_) or_CC in_IN comatose_NN patients_NNS ,_, the_DT diagnosis_NN of_IN sepsis_NN
        remains_VBZ difficult_JJ ._.
        Prompt_NNP diagnosis_NN and_CC treatment_NN with_IN appropriate_JJ
        antimicrobial_NN chemotherapy_NN is_VBZ of_IN the_DT utmost_JJ importance_NN in_IN
        reducing_VBG the_DT morbidity_NN and_CC mortality_NN associated_VBN with_IN
        sepsis_NN ._. The_DT lack_NN of_IN specific_JJ early_JJ markers_NNS of_IN infection_NN may_MD
        be_VB responsible_JJ in_IN part_NN for_IN withholding_NN ,_, delaying_VBG or_CC
        unnecessary_JJ antimicrobial_NN treatment_NN in_IN critically_RB ill_JJ
        patients_NNS [_NN 4_CD ]_NN ._. Thus_RB ,_, there_EX is_VBZ an_DT unmet_JJ need_NN for_IN clinical_JJ or_CC
        laboratory_NN tools_NNS that_WDT can_MD distinguish_VB between_IN SIRS_NNP and_CC
        sepsis_NN ._. Various_JJ markers_NNS of_IN sepsis_NN ,_, including_VBG C-_NNP reactive_JJ
        protein_NN (_( CRP_NNP )_) ,_, tumour_NN necrosis_NNS factor_NN (_( TNF_NNP )_) -_: α_NN ,_, IL-_NNP 1_CD β_NN ,_, IL-_NNP 6_CD
        and_CC IL-_NNP 8_CD ,_, have_VBP all_DT been_VBN studied_VBN for_IN their_PRP$ ability_NN to_TO
        differentiate_VB SIRS_NNP from_IN sepsis_NN [_NN 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ]_NN ._. Several_JJ
        investigators_NNS have_VBP questioned_VBN the_DT diagnostic_JJ accuracy_NN of_IN
        procalcitonin_NN (_( PCT_NNP )_) measurement_NN ,_, results_NNS with_IN which_WDT have_VBP
        been_VBN inconsistent_JJ and_CC variable_JJ [_NN 4_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._. Thus_RB ,_,
        it_PRP may_MD not_RB be_VB easy_JJ to_TO discriminate_JJ between_IN SIRS_NNP and_CC sepsis_NN ,_,
        even_RB with_IN the_DT use_NN of_IN PCT_NNP ._.
        The_DT present_JJ study_NN was_VBD conducted_VBN to_TO determine_VB the_DT
        procalcitonin_NN level_NN at_IN early_JJ diagnosis_NN (_( and_CC
        differentiation_NN )_) in_IN patients_NNS with_IN systemic_JJ inflammatory_JJ
        response_NN syndrome_NN (_( SIRS_NNP )_) and_CC sepsis_NN ,_, in_IN comparison_NN with_IN
        C-_NNP reactive_JJ protein_NN ,_, IL-_NNP 2_CD ,_, IL-_NNP 6_CD ,_, IL-_NNP 8_CD and_CC tumour_NN necrosis_NNS
        factor-α_JJ in_IN an_DT unselected_JJ population_NN of_IN patients_NNS suffering_VBG
        from_IN a_DT broad_JJ range_NN of_IN diseases_NNS in_IN an_DT intensive_JJ care_NN unit_NN
        (_( ICU_NNP )_) ._.
      
      
        Methods_NNP
        
          Laboratory_NN measurements_NNS
          CRP_NNP was_VBD measured_VBN using_VBG a_DT routine_JJ turbidimetry_NN assay_NN
          (_( ILAD-_NNP 900_CD ;_: Instrumentation_NNP Laboratory_NNP ,_, Milan_NNP ,_, Italy_NNP )_) ;_: a_DT
          value_NN greater_JJR than_IN 10_CD mg_NN /_NN l_NN was_VBD considered_VBN to_TO be_VB
          abnormally_RB elevated_VBD ._. TNF-α_NNP ,_, and_CC IL-_NNP 2_CD ,_, IL-_NNP 6_CD and_CC IL-_NNP 8_CD were_VBD
          measured_VBN using_VBG commercially_RB available_JJ cheluminesan_NN kits_NNS
          (_( Immulite-_NNP One_CD ;_: DTC_NNP ,_, Los_NNP Angeles_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. All_DT cytokine_NN
          samples_NNS were_VBD analyzed_VBN in_IN duplicate_VB ._. PCT_NNP levels_NNS (_( normal_JJ
          range_NN 0_CD -_: 0_CD ._. 5_LS ng_NN /_NN l_NN )_) were_VBD determined_VBN by_IN means_NNS of_IN a_DT specific_JJ
          and_CC ultrasensitive_JJ immunoluminometric_JJ assay_NN (_( LUMI_NNP test_NN
          PCT_NNP ;_: Brahms_NNP Ag_NNP ,_, Hennigsdorf_NNP /_NN Berlin_NNP ,_, Germany_NNP )_) ._.
        
        
          Statistical_NNP analysis_NN
          For_IN multiple_JJ group_NN comparisons_NNS of_IN CRP_NNP ,_, ILs_NNP and_CC PCT_NNP ,_,
          one-way_JJ analysis_NN of_IN variance_NN was_VBD applied_VBN ,_, with_IN least_JJS
          squares_NNS difference_NN for_IN 
          post_NN hoc_FW comparison_NN ._. The_DT best_JJS
          cutoff_NN value_NN of_IN parameters_NNS for_IN the_DT diagnosis_NN of_IN sepsis_NN
          was_VBD determined_VBN according_VBG to_TO the_DT Youden_NNP 's_POS index_NN method_NN ._.
          The_DT ability_NN of_IN PCT_NNP to_TO predict_VB sepsis_NN was_VBD evaluated_VBN by_IN
          performing_VBG receiver_NN operative_JJ characteristic_JJ analyses_NNS to_TO
          compare_VB SIRS_NNP versus_CC sepsis_NN patients_NNS [_NN 12_CD ]_NN ._. Furthermore_RB ,_,
          the_DT areas_NNS under_IN the_DT receiver_NN operative_JJ characteristic_JJ
          curve_NN (_( AUCs_NNP )_) were_VBD determined_VBN ,_, as_RB well_RB as_IN the_DT
          positive_JJ /_NN negative_JJ predictive_JJ values_NNS ._. Positive_JJ predictive_JJ
          values_NNS and_CC negative_JJ predictive_JJ values_NNS indicate_VBP the_DT
          proportion_NN of_IN patients_NNS with_IN a_DT cytokine_NN level_NN greater_JJR than_IN
          or_CC below_IN the_DT chosen_VBN cutoff_NN point_NN ._. Test_NN effectiveness_NN is_VBZ
          the_DT sum_NN of_IN the_DT positive_JJ predictive_JJ values_NNS and_CC negative_JJ
          predictive_JJ values_NNS ._. Thus_RB ,_, the_DT maximum_NN score_NN is_VBZ 2_CD ,_, which_WDT
          represents_VBZ perfect_JJ prediction_NN ,_, both_DT positive_JJ and_CC negative_JJ
          [_NN 13_CD ]_NN ._. The_DT septic_JJ shock_NN group_NN was_VBD not_RB included_VBN in_IN this_DT
          analysis_NN because_IN of_IN insufficient_JJ data_NNS ._. Statistical_NNP
          analyses_NNS were_VBD conducted_VBN using_VBG the_DT Statistical_NNP Program_NNP for_IN
          Social_NNP Science_NNP (_( SPSS_NNP ,_, Chicago_NNP ,_, IL_NNP ,_, USA_NNP )_) ._. 
          P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ ._. Data_NNS in_IN the_DT text_NN are_VBP shown_VBN as_IN
          mean_NN ±_NN standard_JJ error_NN ,_, or_CC as_IN median_JJ and_CC percentiles_NNS
          (_( 10_CD %_NN /_NN 25_CD %_NN /_NN 75_CD %_NN /_NN 90_CD %_NN )_) ._.
        
      
      
        Results_NNS
        A_DT total_NN of_IN 33_CD patients_NNS (_( 17_CD men_NNS and_CC 16_CD women_NNS )_) were_VBD
        included_VBN in_IN the_DT study_NN ._. The_DT median_JJ age_NN of_IN the_DT patients_NNS was_VBD
        58_CD ±_NN 16_CD years_NNS ._. The_DT duration_NN of_IN stay_NN of_IN the_DT patients_NNS in_IN the_DT
        ICU_NNP was_VBD 7_CD ._. 4_CD ±_NN 6_CD ._. 78_CD days_NNS ._. The_DT final_JJ ,_, retrospectively_RB
        confirmed_VBD diagnoses_NNS of_IN all_DT patients_NNS are_VBP shown_VBN in_IN Table_NNP
        1_CD ._.
        For_IN each_DT of_IN the_DT time_NN points_NNS assessed_VBN in_IN the_DT present_JJ
        study_NN ,_, patients_NNS were_VBD categorized_VBN into_IN the_DT three_CD groups_NNS ,_,
        namely_RB SIRS_NNP ,_, sepsis_NN and_CC septic_JJ shock_NN ._. No_DT severely_RB septic_JJ
        patients_NNS were_VBD identified_VBN ._. Ten_CD patients_NNS died_VBD on_IN the_DT second_JJ
        day_NN following_VBG admission_NN to_TO the_DT ICU_NNP ,_, and_CC those_DT patients_NNS
        underwent_VBD only_RB two_CD assessments_NNS ._. Thus_RB ,_, a_DT total_NN of_IN 89_CD
        assessments_NNS of_IN the_DT patients_NNS '_POS clinical_JJ status_NN were_VBD conducted_VBN
        (_( referred_VBD to_TO hereafter_RB as_IN '_POS conditions_NNS '_POS )_) ,_, 48_CD of_IN which_WDT
        indicated_VBD SIRS_NNP (_( 53_CD %_NN of_IN all_DT patients_NNS )_) ,_, 35_CD sepsis_NN (_( 39_CD %_NN of_IN all_DT
        patients_NNS )_) and_CC 6_CD septic_JJ shock_NN (_( 7_CD %_NN of_IN all_DT patients_NNS )_) ._.
        Of_IN the_DT 41_CD conditions_NNS of_IN sepsis_NN and_CC septic_JJ shock_NN ,_, 24_CD
        (_( 58_CD %_NN )_) involved_VBN pneumonia_NN ,_, 8_CD (_( 20_CD %_NN )_) urogenital_NN infection_NN ,_, 2_CD
        (_( 5_CD %_NN )_) intraperitoneal_NN abscess_NNS and_CC 5_CD (_( 12_CD %_NN )_) wound_VBD infection_NN ._.
        In_IN three_CD patients_NNS no_DT infectious_JJ focus_NN could_MD be_VB found_VBN ,_, but_CC
        blood_NN cultures_NNS were_VBD positive_JJ ._. Infections_NNP were_VBD
        microbiologically_RB proven_VBN in_IN 36_CD (_( 88_CD %_NN )_) conditions_NNS ,_, with_IN 51_CD %_NN
        being_VBG Gram-negative_NNP ,_, 41_CD %_NN Gram-positive_NNP and_CC 8_CD %_NN mixed_JJ
        infections_NNS ._. Of_IN the_DT five_CD conditions_NNS with_IN SIRS_NNP ,_, tracheal_NN
        cultures_NNS were_VBD positive_JJ but_CC did_VBD not_RB exhibit_VB any_DT host_NN
        response_NN ;_: they_PRP were_VBD therefore_RB considered_VBN colonization_NN ._.
        Eight_CD patients_NNS did_VBD not_RB receive_VB antimicrobial_NN treatment_NN in_IN
        any_DT of_IN the_DT study_NN periods_NNS ._. Five_CD of_IN the_DT patients_NNS who_WP died_VBD
        (_( 5_CD /_NN 6_CD [_NN 83_CD %_NN ]_NN )_) were_VBD in_IN septic_JJ shock_NN group_NN and_CC the_DT other_JJ five_CD
        patients_NNS who_WP died_VBD (_( 5_CD /_NN 35_CD [_NN 14_CD %_NN ]_NN )_) were_VBD in_IN the_DT sepsis_NN
        group_NN ._.
        APACHE-II_NNP scores_NNS did_VBD not_RB differ_VB between_IN groups_NNS ._. No_DT
        correlation_NN was_VBD found_VBN between_IN PCT_NNP concentrations_NNS and_CC
        APACHE-II_NNP scores_NNS (_( 
        r_LS =_SYM 0_CD ._. 23_CD )_) ._. Serum_NNP concentrations_NNS of_IN
        CRP_NNP ,_, TNF-α_NNP and_CC IL-_NNP 6_CD were_VBD not_RB statistically_RB different_JJ
        between_IN SIRS_NNP ,_, sepsis_NN and_CC septic_JJ shock_NN groups_NNS ._. IL-_NNP 2_CD ,_, IL-_NNP 8_CD
        and_CC PCT_NNP levels_NNS were_VBD different_JJ between_IN groups_NNS ._. Septic_NNP shock_NN
        patients_NNS had_VBD the_DT highest_JJS level_NN of_IN IL-_NNP 2_CD ,_, IL-_NNP 8_CD and_CC PCT_NNP
        concentrations_NNS ._. Median_JJ and_CC percentiles_NNS (_( 10_CD /_NN 25_CD /_NN 75_CD /_NN 90_CD %_NN )_) for_IN
        all_DT parameters_NNS and_CC APACHE-II_NNP scores_NNS in_IN patients_NNS with_IN SIRS_NNP ,_,
        sepsis_NN and_CC septic_JJ shock_NN are_VBP presented_VBN in_IN Table_NNP 2_CD ._.
        Because_IN we_PRP only_RB six_CD septic_JJ shock_NN conditions_NNS were_VBD
        identified_VBN ,_, we_PRP employed_VBN only_RB SIRS_NNP and_CC sepsis_NN conditions_NNS for_IN
        statistical_JJ analysis_NN of_IN diagnostic_JJ reliability_NN of_IN serum_NN PCT_NNP
        and_CC cytokines_NNS ._. Using_VBG Youden_NNP 's_POS Index_NNP ,_, the_DT best_JJS cutoff_NN value_NN
        for_IN PCT_NNP was_VBD 2_CD ._. 415_CD ng_NN /_NN ml_NN ._. The_DT best_JJS cut-off_JJ value_NN and_CC AUC_NNP for_IN
        all_DT markers_NNS are_VBP shown_VBN in_IN Table_NNP 3_CD ._. The_DT AUC_NNP was_VBD highest_JJS for_IN
        PCT_NNP ._. Table_NNP 4_CD summarizes_NNS the_DT predictive_JJ accuracy_NN of_IN the_DT
        laboratory_NN variables_NNS for_IN the_DT specific_JJ diagnoses_NNS of_IN SIRS_NNP and_CC
        sepsis_NN ._. With_IN a_DT cutoff_NN point_NN of_IN 2_CD ._. 415_CD ng_NN /_NN ml_NN ,_, serum_NN PCT_NNP
        concentration_NN was_VBD found_VBN to_TO be_VB the_DT most_RBS discriminatory_JJ
        laboratory_NN variable_JJ ,_, the_DT predictive_JJ accuracy_NN of_IN which_WDT
        exceeded_VBD those_DT of_IN CRP_NNP ,_, TNF-α_NNP ,_, IL-_NNP 2_CD ,_, IL-_NNP 6_CD and_CC IL-_NNP 8_CD ._. With_IN
        regard_NN to_TO positive_JJ and_CC negative_JJ predictive_JJ values_NNS ,_, we_PRP found_VBD
        that_IN PCT_NNP markedly_RB exceeds_VBZ the_DT values_NNS calculated_VBN for_IN other_JJ
        variables_NNS ._. The_DT test_NN effectiveness_NN was_VBD 1_CD ._. 84_CD for_IN PCT_NNP in_IN
        predicting_VBG sepsis_NN ,_, whereas_IN the_DT other_JJ variables_NNS reached_VBD
        values_NNS between_IN 0_CD ._. 96_CD and_CC 1_CD ._. 22_CD ._.
      
      
        Discussion_NNP
        We_PRP analyzed_VBD the_DT plasma_NN concentrations_NNS of_IN various_JJ
        biochemical_JJ markers_NNS with_IN respect_NN to_TO their_PRP$ potential_JJ use_NN in_IN
        differentiating_VBG between_IN patients_NNS suffering_VBG from_IN SIRS_NNP and_CC
        from_IN sepsis_NN ._. This_DT assessment_NN is_VBZ of_IN potential_JJ interest_NN
        because_IN systemic_JJ inflammation_NN is_VBZ a_DT common_JJ problem_NN in_IN the_DT
        ICU_NNP ,_, which_WDT often_RB leads_VBZ to_TO shock_VB and_CC death_NN ._. The_DT diagnostic_JJ
        repertoire_NN for_IN identifying_VBG SIRS_NNP is_VBZ poor_JJ ._. Verification_NNP of_IN
        infection_NN site_NN ,_, and_CC even_RB the_DT presence_NN of_IN infection_NN ,_, remains_VBZ
        problematic_JJ in_IN sepsis_NN ._. In_IN 20_CD -_: 30_CD %_NN of_IN patients_NNS ,_, the_DT infection_NN
        site_NN is_VBZ never_RB identified_VBN ._. Neither_DT imaging_NN studies_NNS nor_CC blood_NN
        culture_NN analysis_NN can_MD rule_VB out_RP the_DT presence_NN of_IN infection_NN [_NN
        14_CD ]_NN ._. Moreover_RB ,_, there_EX are_VBP classes_NNS of_IN patients_NNS with_IN
        unconfirmed_JJ infection_NN ,_, or_CC for_IN whom_WP cultures_NNS are_VBP negative_JJ
        yet_RB who_WP develop_VBP similar_JJ symptoms_NNS ,_, rates_NNS of_IN organ_NN failure_NN
        and_CC survival_NN outcomes_NNS as_IN do_VBP those_DT in_IN patients_NNS in_IN whom_WP
        infection_NN is_VBZ confirmed_VBN ._. The_DT availability_NN of_IN laboratory_NN
        tests_NNS for_IN accurate_JJ and_CC rapid_JJ identification_NN of_IN septic_JJ
        patients_NNS by_IN isolation_NN of_IN micro-organisms_JJ from_IN body_NN fluid_JJ
        specimens_NNS would_MD be_VB of_IN considerable_JJ value_NN ._. Thus_RB ,_, there_EX is_VBZ a_DT
        clear_JJ need_NN for_IN a_DT reliable_JJ diagnostic_JJ procedure_NN that_WDT allows_VBZ
        early_JJ discrimination_NN between_IN patients_NNS suffering_VBG from_IN SIRS_NNP
        and_CC those_DT with_IN sepsis_NN ._. A_DT relatively_RB new_JJ marker_NN that_WDT has_VBZ
        been_VBN associated_VBN with_IN inflammation_NN and_CC sepsis_NN is_VBZ PCT_NNP ,_, a_DT
        116_CD -_: amino-acid_JJ protein_NN that_WDT is_VBZ the_DT precursor_NN to_TO calcitonin_NN ._.
        The_DT PCT_NNP plasma_NN level_NN in_IN healthy_JJ individuals_NNS is_VBZ low_JJ ,_, usually_RB
        below_IN 0_CD ._. 1_CD ng_NN /_NN ml_NN [_NN 15_CD ]_NN ._. That_DT PCT_NNP concentration_NN is_VBZ
        significantly_RB elevated_VBD in_IN patients_NNS with_IN organ_NN dysfunction_NN
        is_VBZ undoubted_JJ ._. However_RB ,_, the_DT difference_NN in_IN PCT_NNP between_IN
        patients_NNS with_IN SIRS_NNP and_CC those_DT with_IN sepsis_NN may_MD be_VB small_JJ ._.
        Reports_NNS of_IN the_DT usefulness_NN of_IN PCT_NNP for_IN discriminating_VBG between_IN
        SIRS_NNP and_CC sepsis_NN are_VBP conflicting_JJ [_NN 4_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._.
        Therefore_RB ,_, we_PRP selected_VBD several_JJ cytokines_NNS as_RB well_RB as_IN PCT_NNP for_IN
        early_JJ diagnosis_NN (_( and_CC differentiation_NN )_) of_IN patients_NNS with_IN SIRS_NNP
        and_CC sepsis_NN ._.
        High_JJ serum_NN PCT_NNP concentrations_NNS were_VBD first_RB described_VBN by_IN
        Assicot_NNP and_CC coworkers_NNS [_NN 16_CD ]_NN in_IN children_NNS with_IN severe_JJ
        bacterial_JJ infections_NNS ,_, and_CC were_VBD suggested_VBN to_TO be_VB a_DT specific_JJ
        marker_NN for_IN bacterial_JJ infection_NN ._. Al-_NNP Nawas_NNP and_CC coworkers_NNS [_NN
        17_CD ]_NN reported_VBD higher_JJR PCT_NNP levels_NNS in_IN patients_NNS with_IN clinically_RB
        documented_VBN infection_NN than_IN in_IN those_DT fulfilling_VBG the_DT criteria_NNS
        for_IN SIRS_NNP ._.
        Two_CD studies_NNS compared_VBD PCT_NNP and_CC CRP_NNP in_IN ICU_NNP patients_NNS and_CC
        found_VBD that_IN PCT_NNP had_VBD poorer_JJR sensitivity_NN ,_, specificity_NN and_CC AUC_NNP
        than_IN did_VBD CRP_NNP as_IN a_DT marker_NN of_IN sepsis_NN [_NN 8_CD ,_, 10_CD ]_NN ._. In_IN order_NN to_TO
        assess_VB the_DT diagnostic_JJ utility_NN of_IN PCT_NNP and_CC CRP_NNP in_IN a_DT medical_JJ
        ICU_NNP ,_, prospective_JJ measurements_NNS were_VBD conducted_VBN in_IN 101_CD
        consecutive_JJ patients_NNS with_IN acute_JJ SIRS_NNP or_CC sepsis_NN ._. PCT_NNP did_VBD not_RB
        clearly_RB discriminate_JJ SIRS_NNP from_IN sepsis_NN [_NN 8_CD ]_NN ._. Another_DT group_NN
        from_IN Germany_NNP reported_VBD average_JJ PCT_NNP concentrations_NNS of_IN 0_CD ._. 4_CD ±_NN
        3_CD ._. 0_CD ng_NN /_NN ml_NN for_IN SIRS_NNP ,_, 0_CD ._. 5_CD ±_NN 2_CD ._. 9_CD ng_NN /_NN ml_NN for_IN sepsis_NN and_CC 6_CD ._. 9_CD ±_NN
        3_CD ._. 9_CD ng_NN /_NN ml_NN for_IN severe_JJ sepsis_NN ._. On_IN the_DT basis_NN of_IN their_PRP$
        findings_NNS ,_, the_DT investigators_NNS concluded_VBD that_IN PCT_NNP ,_, CRP_NNP ,_, white_JJ
        blood_NN cell_NN and_CC body_NN temperature_NN does_VBZ not_RB discriminate_JJ SIRS_NNP
        from_IN sepsis_NN ,_, and_CC PCT_NNP was_VBD the_DT only_JJ parameter_NN to_TO discriminate_JJ
        between_IN sepsis_NN and_CC severe_JJ sepsis_NN [_NN 9_CD ]_NN ._.
        Muller_NNP and_CC colleagues_NNS [_NN 4_CD ]_NN investigated_VBD 101_CD patients_NNS
        admitted_VBN to_TO a_DT medical_JJ ICU_NNP and_CC suggested_VBD that_IN PCT_NNP is_VBZ a_DT more_RBR
        reliable_JJ marker_NN of_IN sepsis_NN than_IN is_VBZ CRP_NNP ,_, IL-_NNP 6_CD and_CC lactate_NN
        levels_NNS ._. To_TO assess_VB the_DT diagnostic_JJ value_NN of_IN PCT_NNP ,_, IL-_NNP 6_CD ,_, IL-_NNP 8_CD
        and_CC standard_JJ measures_NNS for_IN identifying_VBG critically_RB ill_JJ
        patients_NNS with_IN SIRS_NNP and_CC suspected_VBN sepsis_NN ,_, prospective_JJ
        measurements_NNS were_VBD taken_VBN in_IN 78_CD consecutive_JJ patients_NNS admitted_VBN
        with_IN acute_JJ SIRS_NNP and_CC suspected_VBN infection_NN ._. PCT_NNP yielded_VBD the_DT
        highest_JJS discriminative_JJ value_NN for_IN differentiating_VBG patients_NNS
        with_IN SIRS_NNP from_IN those_DT with_IN sepsis_NN ,_, followed_VBN by_IN IL-_NNP 6_CD and_CC IL-_NNP 8_CD
        [_NN 6_CD ]_NN ._. Selberg_NNP and_CC coworkers_NNS [_NN 7_CD ]_NN studied_VBD discrimination_NN of_IN
        sepsis_NN and_CC SIRS_NNP by_IN determination_NN of_IN circulating_VBG plasma_NN
        concentrations_NNS of_IN PCT_NNP ,_, IL-_NNP 6_CD and_CC C_NNP 3_CD a_DT in_IN a_DT medical_JJ ICU_NNP ._. Their_PRP$
        data_NNS indicated_VBD that_IN of_IN PCT_NNP ,_, IL-_NNP 6_CD and_CC C_NNP 3_CD a_DT concentrations_NNS are_NN
        more_RBR reliable_JJ parameter_NN for_IN differentiating_VBG between_IN septic_JJ
        and_CC SIRS_NNP patients_NNS than_IN are_VBP CRP_NNP and_CC elastase_NN ._.
        Mechanical_NNP trauma_NN causes_NNS elevated_VBD PCT_NNP levels_NNS ,_, the_DT degree_NN
        of_IN which_WDT depends_VBZ on_IN the_DT severity_NN of_IN the_DT injury_NN ._. Levels_NNP peak_NN
        on_IN days_NNS 1_CD -_: 3_CD and_CC fall_NN thereafter_RB ._. High_JJ concentrations_NNS of_IN
        circulating_VBG PCT_NNP during_IN the_DT first_JJ 3_CD days_NNS after_IN injury_NN
        discriminate_JJ between_IN patients_NNS at_IN risk_NN for_IN SIRS_NNP ,_, sepsis_NN and_CC
        multiple_JJ organ_NN dysfunctions_NNS in_IN the_DT early_JJ and_CC late_JJ
        post-traumatic_JJ course_NN [_NN 18_CD ]_NN ._.
        Previous_JJ studies_NNS compared_VBD CRP_NNP ,_, IL-_NNP 2_CD ,_, IL-_NNP 6_CD ,_, and_CC TNF-α_NNP and_CC
        PCT_NNP separately_RB for_IN differentiating_VBG SIRS_NNP from_IN sepsis_NN ;_: in_IN the_DT
        present_JJ study_NN ,_, all_DT of_IN the_DT available_JJ biochemical_JJ markers_NNS
        were_VBD measured_VBN at_IN the_DT same_JJ time_NN [_NN 4_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._. PCT_NNP had_VBD
        the_DT highest_JJS sensitivity_NN and_CC specificity_NN for_IN differentiating_VBG
        SIRS_NNP from_IN sepsis_NN ,_, followed_VBN by_IN IL-_NNP 2_CD and_CC IL-_NNP 8_CD ._. Thus_RB ,_, in_IN
        agreement_NN with_IN previous_JJ studies_NNS [_NN 6_CD ,_, 7_CD ]_NN ,_, PCT_NNP was_VBD a_DT more_RBR
        reliable_JJ marker_NN in_IN the_DT diagnosis_NN of_IN sepsis_NN than_IN other_JJ
        measures_NNS ._.
        The_DT present_JJ study_NN included_VBD consecutive_JJ unselected_JJ
        patients_NNS who_WP were_VBD representative_NN of_IN an_DT ICU_NNP population_NN ,_, with_IN
        baseline_NN characteristics_NNS similar_JJ those_DT reported_VBD in_IN the_DT
        literature_NN ,_, and_CC strict_JJ objective_NN criteria_NNS for_IN the_DT diagnosis_NN
        of_IN infection_NN were_VBD employed_VBN [_NN 19_CD ]_NN ._. However_RB ,_, several_JJ
        criticisms_NNS of_IN the_DT study_NN should_MD be_VB addressed_VBN ._. First_LS ,_, PCT_NNP was_VBD
        not_RB monitored_VBN every_DT day_NN ,_, and_CC a_DT shorter_JJR monitoring_VBG interval_NN
        may_MD improve_VB its_PRP$ performance_NN as_IN an_DT aid_NN for_IN diagnosis_NN and_CC
        follow_VB up_RB of_IN sepsis_NN ._. Second_JJ ,_, with_IN the_DT use_NN of_IN clinical_JJ
        criteria_NNS and_CC microbiological_JJ evidence_NN ,_, it_PRP might_MD have_VB been_VBN
        difficult_JJ to_TO ascertain_VB the_DT exact_JJ aetiology_NN of_IN SIRS_NNP in_IN all_DT
        patients_NNS ._. This_DT may_MD have_VB introduced_VBN some_DT misclassification_NN
        bias_NN ,_, because_IN investigators_NNS who_WP were_VBD blinded_JJ to_TO the_DT
        cytokine_NN results_NNS performed_VBD the_DT case_NN ascertainment_NN ;_: however_RB ,_,
        we_PRP do_VBP not_RB believe_VB this_DT lack_NN of_IN an_DT important_JJ standard_JJ
        compromised_VBN our_PRP$ study_NN conclusions_NNS ._. Third_NNP ,_, antimicrobial_NN
        therapy_NN may_MD have_VB an_DT impact_NN on_IN PCT_NNP values_NNS ._. Our_PRP$ study_NN design_NN
        does_VBZ not_RB allow_VB us_PRP to_TO explain_VB the_DT exact_JJ relationship_NN between_IN
        antimicrobial_NN therapy_NN and_CC PCT_NNP values_NNS ._. The_DT temporal_JJ
        relationship_NN between_IN PCT_NNP and_CC antibiotic_JJ treatment_NN should_MD be_VB
        assessed_VBN in_IN further_JJ studies_NNS ._.
      
      
        Conclusion_NNP
        In_IN the_DT present_JJ study_NN ,_, PCT_NNP appeared_VBD to_TO be_VB a_DT more_RBR accurate_JJ
        diagnostic_JJ parameter_NN for_IN differentiating_VBG between_IN patients_NNS
        suffering_VBG from_IN SIRS_NNP and_CC those_DT with_IN sepsis_NN ._. Routine_NNP
        determination_NN of_IN PCT_NNP may_MD improve_VB management_NN of_IN patients_NNS ,_,
        for_IN example_NN by_IN preventing_VBG the_DT use_NN of_IN unnecessary_JJ
        antibiotics_NNS that_WDT are_VBP known_VBN to_TO select_VB resistance_NN strains_NNS ._.
        Further_RB studies_VBZ of_IN the_DT early_JJ phases_NNS of_IN sepsis_NN are_VBP necessary_JJ
        to_TO define_VB the_DT role_NN of_IN PCT_NNP in_IN possible_JJ therapeutic_JJ
        strategies_NNS ,_, such_JJ as_IN antimicrobial_NN and_CC immunological_JJ
        therapies_NNS ,_, and_CC cost_NN implcations_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Key_JJ message_NN
        •_NN PCT_NNP appears_VBZ to_TO be_VB a_DT useful_JJ early_JJ marker_NN for_IN
        discriminating_VBG between_IN SIRS_NNP and_CC sepsis_NN
      
      
        Abbreviations_NNP
        APACHE_NNP =_SYM Acute_NNP Physiology_NNP and_CC Chronic_NNP Health_NNP Evaluation_NNP ;_:
        AUC_NNP =_SYM area_NN under_IN the_DT receiver_NN operating_VBG characteristic_JJ
        curve_NN ;_: CRP_NNP =_SYM C-_NNP reactive_JJ protein_NN ;_: ICU_NNP =_SYM intensive_JJ care_NN unit_NN ;_:
        IL_NNP =_SYM interleukin_NN ;_: PCT_NNP =_SYM procalcitonin_NN ;_: SIRS_NNP =_SYM systemic_JJ
        inflammatory_JJ response_NN syndrome_NN ;_: TNF_NNP =_SYM tumour_NN necrosis_NNS
        factor_NN ._.
      
    
  
